We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
RESEARCH From the Research Desk — The sub-Rs 100 crore acquisition market, sized. Read it →
Home/ Cases/ SOCRUS PHARMACEUTICALS LIMITED
● UNDER CIRP

SOCRUS PHARMACEUTICALS LIMITED

Corporate insolvency resolution — proceedings ongoing · source: Live - Newly Admitted

Activity established in admission dispute: purchase of chickpeas (Dollar Chana); current pharmaceutical operations require further primary verification. · 40 years old at admission

Bench NCLT Indore CIN U24232MP1986PLC003300 Admitted 04 Aug 2026 Initiated by OC — Maa Annapurna Traders Last process activity 06 Aug 2026 · public announcement · active
OWED MONEY BY THIS COMPANY?
The date in the public announcement passed on 18 Aug 2026, but the window has not shut. Regulation 12 lets a creditor file up to 2 Nov 2026 — 39 days left — ninety days from admission on 4 Aug 2026, or later still if the request for resolution plans has not yet gone out. File with kuldeep tank now.
Reg. 12, IBBI (CIRP) Regulations 2016
How to file your claim → The professional’s record →

Case record

the public record -- figures open below

Corporate insolvency record of SOCRUS PHARMACEUTICALS LIMITED, commenced 04 Aug 2026, at NCLT Indore, initiated by OC Maa Annapurna Traders. Current status: Under CIRP.

CIN
U24232MP1986PLC003300
Incorporated
1986
Registered State
Madhya Pradesh
NCLT Bench
Indore
Initiated by
OC Maa Annapurna Traders
Public Announcement
06 Aug 2026
Commencement
04 Aug 2026
Resolution Professional
Subscriber access

Full case intelligence is gated

This page's financial detail is available to stressed.in subscribers — for ARCs, PE funds and resolution professionals.

Admitted claims Recovery waterfall & haircut Sector benchmarks Case timeline & professionals Committee of creditors Plan value & CoC vote Intelligence note
See plans →
Just this company — Rs 1,799 · apply for access →

One company, bought outright — yours permanently, including future updates. Subscribe within 30 days and the whole Rs 1,799 comes off your first month, so starting with one case costs nothing against subscribing later.

Questions? WhatsApp us →
Sources, basis and disclaimers → ·
report an error